Home Monitoring of Cardiac Devices in the Era of COVID-19
- PDF / 658,318 Bytes
- 9 Pages / 595.276 x 790.866 pts Page_size
- 2 Downloads / 157 Views
INVASIVE ELECTROPHYSIOLOGY AND PACING (E KEVIN HEIST, SECTION EDITOR)
Home Monitoring of Cardiac Devices in the Era of COVID-19 Jennifer C. Miller 1 & Devin Skoll 1 & Leslie A. Saxon 1 Accepted: 11 November 2020 # Springer Science+Business Media, LLC, part of Springer Nature 2020
Abstract Purpose of Review Despite the promise of remote patient monitoring (RPM), this technology remained underutilized secondary to a lack of data transparency and systems issues until the COVID-19 pandemic ushered in a new era of telehealth and virtual solutions out of necessity. This review will explore the data supporting the use of RPM via both implantable and wearable devices in the field of cardiology and the role of home monitoring using RPM in the era of COVID-19. Recent Findings RPM using implantable cardiac devices is a safe alternative to in-person only visits which leads to enhanced patient satisfaction and improved clinical outcomes. Consumer-grade wearable sensors have drastically expanded RPM capabilities from just the sickest cardiac patients to the entire population aiding in early diagnosis and real-time disease management. Summary Home monitoring enabled by automated alert systems tailored specifically to the needs of the patient by the provider will be the cornerstone of a more continuous, patent-centric healthcare model. Keywords Remote patient monitoring . Implantable cardiovascular sensors and devices . COVID-19 . Hemodynamic monitoring . Heart failure . Arrhythmia
Introduction A new era of cardiac management began in 1960 with the creation of the first implantable pacemaker which has since saved countless lives and transformed the practice of medicine [1]. This life-saving technology evolved over the next 60 years to include implantable cardiac defibrillators (ICDs) with capabilities such as cardiac resynchronization therapy (CRT) enabling medical providers to safely manage patients with dangerous arrhythmias and congestive heart failure outside the confines of the hospital. A pivotal step in the advancement of this technology was the implementation of remote patient monitoring (RPM). One of the first and the largest RPM studies, the
This article is part of the Topical Collection on Invasive Electrophysiology and Pacing * Leslie A. Saxon [email protected] Jennifer C. Miller [email protected] Devin Skoll [email protected] 1
University of Southern California’s Center for Body Computing, 12015 E Waterfront Dr, Los Angeles, CA 90094, USA
ALTITUDE study, demonstrated a 50% reduction in 1- and 5year mortality rates for patients whose devices were followed remotely versus those with a standard in-person follow-up [2]. Subsequent studies confirmed this survival benefit [3] and demonstrated survival could be further increased with better patient compliance (completion of > 75% of weekly transmissions) [4]. Today, RPM has become the standard of care for patients with implantable cardiac devices [5] and the field has rapidly expanded to include implantable sensors, such as pulmonary artery pressure monitors and implanta
Data Loading...
